Cancer Screening in the 21 Century: State of the Art Cancer Screening
Cancer Screening in the 21 Century: State of the Art Cancer Screening
The American Cancer Society (ACS) publishes guidelines for early cancer screening based on age, gender, family history, among other factors. Cancer screening is a complex process, which includes physical diagnosis, family history, genetics, among other factors.
Today, cancer screening is performed by healthcare providers of various specialties: general and internal medicine practitioners, gynecologists, family physicians, and others. Although cancer screening is a part of the residency and fellowship training for many specialties, it is not their primary focus. On the other hand, specialists in oncology are occupied with treating patients with already established diagnoses of various malignancies rather than screening for and preventing them.
The goal of cancer screening is to detect cancer or its precursor lesions at an early stage when treatment is most effective, preferably prior to the onset of symptoms.
CitiScreen puts together a fragmented screening system by creating screening algorithms for various cancers. An individual screening algorithm combines ultrasound, MRI, CT imaging, genetic and tumor markers, as well as other technologies. Screening starts with obtaining family, personal, and social history, as well as demographics for identification of risk factors. These are followed by genetic profiling tailored to the individual. The data is used to create an algorithm for each individual to prevent cancer for years to come.
About the Author:
Dr. Petrikovsky completed his postgraduate training at SUNY Downstate Maimonides Medical Center (Brooklyn, NY) followed by a fellowship at the University of Connecticut. In 1988, he was a visiting researcher at Kings College School of Medicine (London, UK). He has published over 200 peer-reviewed articles, two textbooks, and ten book chapters. His research awards include a Recognition Award of the Brooklyn Gynecologic Society and the Obstetrical Society of Boston. He also has received the Howard Levine, MD Science Award, a Traveling Fellowship from Bristol-Myers, Squibble/Mead Johnson, and the Award of the Italian Society of Perinatal Medicine. Dr. Petrikovsky is a member of the Editorial Board of the Journal of Neonatal Intensive Care and Ultrasound Diagnosis in OB/GYN. He also served as an independent reviewer for a number of journals including the American Journal of Obstetrics and Gynecology and the Journal of Clinical Ultrasound. Dr. Petrikovsky is board certified in Obstetrics and
Today, cancer screening is performed by healthcare providers of various specialties: general and internal medicine practitioners, gynecologists, family physicians, and others. Although cancer screening is a part of the residency and fellowship training for many specialties, it is not their primary focus. On the other hand, specialists in oncology are occupied with treating patients with already established diagnoses of various malignancies rather than screening for and preventing them.
The goal of cancer screening is to detect cancer or its precursor lesions at an early stage when treatment is most effective, preferably prior to the onset of symptoms.
CitiScreen puts together a fragmented screening system by creating screening algorithms for various cancers. An individual screening algorithm combines ultrasound, MRI, CT imaging, genetic and tumor markers, as well as other technologies. Screening starts with obtaining family, personal, and social history, as well as demographics for identification of risk factors. These are followed by genetic profiling tailored to the individual. The data is used to create an algorithm for each individual to prevent cancer for years to come.
About the Author:
Dr. Petrikovsky completed his postgraduate training at SUNY Downstate Maimonides Medical Center (Brooklyn, NY) followed by a fellowship at the University of Connecticut. In 1988, he was a visiting researcher at Kings College School of Medicine (London, UK). He has published over 200 peer-reviewed articles, two textbooks, and ten book chapters. His research awards include a Recognition Award of the Brooklyn Gynecologic Society and the Obstetrical Society of Boston. He also has received the Howard Levine, MD Science Award, a Traveling Fellowship from Bristol-Myers, Squibble/Mead Johnson, and the Award of the Italian Society of Perinatal Medicine. Dr. Petrikovsky is a member of the Editorial Board of the Journal of Neonatal Intensive Care and Ultrasound Diagnosis in OB/GYN. He also served as an independent reviewer for a number of journals including the American Journal of Obstetrics and Gynecology and the Journal of Clinical Ultrasound. Dr. Petrikovsky is board certified in Obstetrics and
PRP: 298.38 Lei
Acesta este Prețul Recomandat de Producător. Prețul de vânzare al produsului este afișat mai jos.
268.54Lei
268.54Lei
298.38 LeiPrimești 268 puncte
Livrare in 2-4 saptamani
Descrierea produsului
The American Cancer Society (ACS) publishes guidelines for early cancer screening based on age, gender, family history, among other factors. Cancer screening is a complex process, which includes physical diagnosis, family history, genetics, among other factors.
Today, cancer screening is performed by healthcare providers of various specialties: general and internal medicine practitioners, gynecologists, family physicians, and others. Although cancer screening is a part of the residency and fellowship training for many specialties, it is not their primary focus. On the other hand, specialists in oncology are occupied with treating patients with already established diagnoses of various malignancies rather than screening for and preventing them.
The goal of cancer screening is to detect cancer or its precursor lesions at an early stage when treatment is most effective, preferably prior to the onset of symptoms.
CitiScreen puts together a fragmented screening system by creating screening algorithms for various cancers. An individual screening algorithm combines ultrasound, MRI, CT imaging, genetic and tumor markers, as well as other technologies. Screening starts with obtaining family, personal, and social history, as well as demographics for identification of risk factors. These are followed by genetic profiling tailored to the individual. The data is used to create an algorithm for each individual to prevent cancer for years to come.
About the Author:
Dr. Petrikovsky completed his postgraduate training at SUNY Downstate Maimonides Medical Center (Brooklyn, NY) followed by a fellowship at the University of Connecticut. In 1988, he was a visiting researcher at Kings College School of Medicine (London, UK). He has published over 200 peer-reviewed articles, two textbooks, and ten book chapters. His research awards include a Recognition Award of the Brooklyn Gynecologic Society and the Obstetrical Society of Boston. He also has received the Howard Levine, MD Science Award, a Traveling Fellowship from Bristol-Myers, Squibble/Mead Johnson, and the Award of the Italian Society of Perinatal Medicine. Dr. Petrikovsky is a member of the Editorial Board of the Journal of Neonatal Intensive Care and Ultrasound Diagnosis in OB/GYN. He also served as an independent reviewer for a number of journals including the American Journal of Obstetrics and Gynecology and the Journal of Clinical Ultrasound. Dr. Petrikovsky is board certified in Obstetrics and
Today, cancer screening is performed by healthcare providers of various specialties: general and internal medicine practitioners, gynecologists, family physicians, and others. Although cancer screening is a part of the residency and fellowship training for many specialties, it is not their primary focus. On the other hand, specialists in oncology are occupied with treating patients with already established diagnoses of various malignancies rather than screening for and preventing them.
The goal of cancer screening is to detect cancer or its precursor lesions at an early stage when treatment is most effective, preferably prior to the onset of symptoms.
CitiScreen puts together a fragmented screening system by creating screening algorithms for various cancers. An individual screening algorithm combines ultrasound, MRI, CT imaging, genetic and tumor markers, as well as other technologies. Screening starts with obtaining family, personal, and social history, as well as demographics for identification of risk factors. These are followed by genetic profiling tailored to the individual. The data is used to create an algorithm for each individual to prevent cancer for years to come.
About the Author:
Dr. Petrikovsky completed his postgraduate training at SUNY Downstate Maimonides Medical Center (Brooklyn, NY) followed by a fellowship at the University of Connecticut. In 1988, he was a visiting researcher at Kings College School of Medicine (London, UK). He has published over 200 peer-reviewed articles, two textbooks, and ten book chapters. His research awards include a Recognition Award of the Brooklyn Gynecologic Society and the Obstetrical Society of Boston. He also has received the Howard Levine, MD Science Award, a Traveling Fellowship from Bristol-Myers, Squibble/Mead Johnson, and the Award of the Italian Society of Perinatal Medicine. Dr. Petrikovsky is a member of the Editorial Board of the Journal of Neonatal Intensive Care and Ultrasound Diagnosis in OB/GYN. He also served as an independent reviewer for a number of journals including the American Journal of Obstetrics and Gynecology and the Journal of Clinical Ultrasound. Dr. Petrikovsky is board certified in Obstetrics and
Detaliile produsului
